ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,193, issued on Nov. 18, was assigned to National Jewish Health (Denver).
"Methods and compositions for treating and preventing respiratory related diseases and conditions with xylitol-headgroup lipid analogs" was invented by Dennis R. Voelker (Littleton, Colo.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention generally relates to methods to prevent and/or inhibit viral infection as well as to inhibit inflammation and/or pathogen infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual. The invention also relates to methods to prevent or inhibit respiratory s...